Literature DB >> 427715

Hodgkin's disease, stages I and II: relationship of recurrence to size of disease, radiation dose, and number of sites involved.

T L Thar, R R Million, R J Hausner, M H McKetty.   

Abstract

A total of 57 patients with Hodgkin's disease limited to above the diaphragm (Stages I and II, A and B) were treated with radiation therapy alone at the University of Florida between 1964 and 1974. Staging laparotomy was done on 24 patients (42%). A total of 16 patients have relapsed, 4 within the treatment fields, 3 marginally, and 9 as extensions. Analysis of dose vs. size showed no in-field failure with disease less than 6 cm in size, with a range of doses. Massive disease continued to recur occasionally, even with higher doses. Most of the massive disease was mediastinal or hilar; the risk of lung or pleural involvement as determined by x-ray and/or biopsy showed a dramatic increase with size of mediastinal/hilar disease. Only 2 (5%) of 43 patients with mediastinal disease less than 6 cm in size had lung or pleural involvement, compared with 10 (71%) of 14 patients with disease greater than 6 cm in size. Both in-field recurrence and generalized relapse were closely related to the number of anatomical sites involved. Treatment programs need to consider tumor size, particularly in the mediastinum, and the number of sites involved.

Entities:  

Mesh:

Year:  1979        PMID: 427715     DOI: 10.1002/1097-0142(197903)43:3<1101::aid-cncr2820430348>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Early-stage Hodgkin's disease: current approaches to treatment.

Authors:  J J Rusthoven; R MacKenzie
Journal:  Can Med Assoc J       Date:  1985-08-01       Impact factor: 8.262

Review 2.  Extended-field isocentric irradiation for Hodgkin's disease.

Authors:  P P Kumar; R R Good; E O Jones; J E Somers; B E McAnulty; G F McCaul; S S Rogers; M A Reeves; C K Sanders
Journal:  J Natl Med Assoc       Date:  1987-09       Impact factor: 1.798

3.  [Treatment results of Hodgkin's disease, stages I and II (author's transl)].

Authors:  W Gassmann; H Pralle; H Löffler; M Gluth-Stender
Journal:  Klin Wochenschr       Date:  1981-05-15

4.  Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma.

Authors:  Kheng-Wei Yeoh; N George Mikhaeel
Journal:  Adv Hematol       Date:  2010-10-24

5.  Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.

Authors:  Lorraine Krebs; Sandy Amorin; Pauline Brice; Sophie Guillerm; Jean Menard; Christophe Hennequin; Laurent Quéro
Journal:  Strahlenther Onkol       Date:  2016-06-17       Impact factor: 3.621

6.  Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy.

Authors:  L Specht; A M Nordentoft; S Cold; N T Clausen; N I Nissen
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.